Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,674 | 327 | 90.3% |
| Education | $612.71 | 8 | 9.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,474 | 99 | $0 (2024) |
| Janssen Biotech, Inc. | $855.77 | 30 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $597.21 | 24 | $0 (2024) |
| Amgen Inc. | $538.06 | 36 | $0 (2024) |
| PFIZER INC. | $416.41 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $353.42 | 17 | $0 (2024) |
| UCB, Inc. | $345.83 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $314.12 | 16 | $0 (2024) |
| Horizon Therapeutics plc | $242.98 | 16 | $0 (2023) |
| ANI Pharmaceuticals, Inc. | $174.59 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,459 | 110 | ABBVIE INC. ($822.19) |
| 2023 | $2,410 | 143 | ABBVIE INC. ($416.85) |
| 2022 | $1,417 | 82 | Janssen Biotech, Inc. ($235.16) |
All Payment Transactions
335 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $56.56 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,415 | 54,830 | $909,665 | $394,715 |
| 2022 | 11 | 659 | 53,490 | $983,057 | $476,930 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 38 | 48,400 | $484,000 | $186,971 | 38.6% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 18 | 4,300 | $258,000 | $144,381 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 500 | $72,500 | $34,687 | 47.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 38 | 242 | $36,300 | $10,730 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 143 | $14,300 | $7,073 | 49.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 40 | 103 | $10,300 | $3,967 | 38.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 122 | 152 | $1,520 | $1,263 | 83.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 126 | 166 | $6,640 | $1,252 | 18.9% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 124 | 157 | $5,495 | $790.14 | 14.4% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 109 | 129 | $3,225 | $531.11 | 16.5% |
| 82565 | Blood creatinine level | Office | 2023 | 85 | 98 | $2,450 | $489.59 | 20.0% |
| 84460 | Liver enzyme (sgpt), level | Office | 2023 | 80 | 90 | $2,250 | $464.64 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 56 | $1,400 | $453.06 | 32.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 40 | 42 | $3,570 | $430.00 | 12.0% |
| 80076 | Liver function blood test panel | Office | 2023 | 46 | 48 | $3,600 | $376.47 | 10.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 44 | 44 | $2,200 | $356.47 | 16.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 13 | 14 | $420.00 | $172.90 | 41.2% |
| 84450 | Liver enzyme (sgot), level | Office | 2023 | 28 | 31 | $775.00 | $157.48 | 20.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 18 | 18 | $450.00 | $114.12 | 25.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 69 | $241.50 | $44.22 | 18.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 12 | 28 | $28.00 | $11.33 | 40.5% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 34 | 41,600 | $416,000 | $178,634 | 42.9% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 24 | 5,050 | $301,125 | $173,885 | 57.7% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 12 | 5,550 | $144,000 | $64,378 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 316 | 568 | $82,360 | $43,698 | 53.1% |
About Heather Roy
Heather Roy is a Nurse Practitioner healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2019. The National Provider Identifier (NPI) number assigned to this provider is 1437702511.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Roy has received a total of $6,286 in payments from pharmaceutical and medical device companies, with $2,459 received in 2024. These payments were reported across 335 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,674).
As a Medicare-enrolled provider, Roy has provided services to 2,074 Medicare beneficiaries, totaling 108,320 services with total Medicare billing of $871,645. Data is available for 2 years (2022–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Fort Wayne, IN
- Active Since 07/18/2019
- Last Updated 05/02/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1437702511
Products in Payments
- RINVOQ (Biological) $1,059
- TREMFYA (Drug) $762.93
- ACTHAR (Biological) $597.21
- XELJANZ (Drug) $416.41
- BENLYSTA (Biological) $353.42
- SKYRIZI (Biological) $349.16
- Cimzia (Drug) $345.83
- Enbrel (Biological) $306.62
- KRYSTEXXA (Biological) $247.82
- COSENTYX (Drug) $211.12
- PURIFIED CORTROPHIN GEL (Drug) $197.08
- LUPKYNIS (Drug) $153.04
- TALTZ (Drug) $137.71
- KEVZARA (Biological) $105.21
- COSENTYX (Biological) $103.00
- TAVNEOS (Drug) $93.94
- REMICADE (Biological) $92.84
- HADLIMA (Drug) $90.95
- ORENCIA (Biological) $87.52
- RAYOS (Drug) $86.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Fort Wayne
Kristine Taylor
Nurse Practitioner — Payments: $49,536
Sean Goddard, Np, NP
Nurse Practitioner — Payments: $45,835
Mary Bullis, Np, NP
Nurse Practitioner — Payments: $27,016
Mr. Nathan Miner, Pmhnp, PMHNP
Nurse Practitioner — Payments: $14,237
Gabriela North, Fnp-C, Fnp-Bc, FNP-C, FNP-BC
Nurse Practitioner — Payments: $14,092
Joel Nagel, Np, NP
Nurse Practitioner — Payments: $9,342